Consolidated Balance Sheets (USD $) In Millions, except Share data in Thousands, unless otherwise specified	Mar. 31, 2015		Dec. 31, 2014
Assets
Cash and Due from Banks	$ 6,483		$ 7,047
Federal Funds Sold and Securities Purchased under Agreements to Resell	1,233		1,160
Interest-bearing Deposits in Banks and Other Financial Institutions	22		22
Cash and cash equivalents	7,738		8,229
Trading assets	6,595	[1]	6,202	[1]
Available-for-sale Securities	26,761	[2]	26,770	[2]
Loans Held for Sale	3,404	[3]	3,232	[3]
Loans held for investment	132,380	[4]	133,112	[4]
Loans and Leases Receivable, Allowance	(1,893)		(1,937)
Net loans	130,487		131,175
Premises and equipment	1,494		1,508
Goodwill	6,337		6,337
Intangible Assets, Net (Excluding Goodwill)	1,193		1,219
Other Assets	5,872		5,656
Total assets	189,881		190,328
Liabilities and Shareholders' Equity
Noninterest-bearing consumer and commercial deposits	42,376		41,096
Interest-bearing Deposit Liabilities	102,047		99,471
Total deposits	144,423		140,567
Funds purchased	1,299		1,276
Securities Sold under Agreements to Repurchase	1,845	[5]	2,276	[5]
Other Short-term Borrowings	1,438		5,634
Long-term Debt	13,012	[6]	13,022	[6]
Trading liabilities	1,459		1,227
Other Liabilities	3,145		3,321
Total liabilities	166,621		167,323
Preferred Stock, Value, Outstanding	1,225		1,225
Common Stock, Value, Outstanding	550		550
Additional paid in capital	9,074		9,089
Retained earnings	13,600		13,295
Treasury stock, at cost, and other	(1,124)	[7]	(1,032)	[7]
Accumulated Other Comprehensive Income (Loss), Net of Tax	(65)		(122)
Total shareholders' equity	23,260		23,005
Total liabilities and shareholders' equity	189,881		190,328
Common Stock, Shares, Outstanding	522,031	[8]	524,540	[8]
Common shares authorized	750,000		750,000
Preferred Stock, Shares Outstanding	12		12
Preferred Stock, Shares Authorized	50,000		50,000
Treasury shares of common stock	27,890		25,381
Treasury Stock and Other
Liabilities and Shareholders' Equity
Treasury stock, at cost, and other	1,215
Total shareholders' equity	(1,124)	[9]	(1,032)	[9]
Stockholders' Equity Attributable to Noncontrolling Interest	106		108
Variable Interest Entity, Primary Beneficiary [Member]
Assets
Loans held for investment	277		288
Liabilities and Shareholders' Equity
Long-term Debt	292		302
Restricted Stock [Member]
Liabilities and Shareholders' Equity
Common Stock, Shares, Outstanding	1,712		2,930
Trading Securities [Member]
Liabilities and Shareholders' Equity
Pledged Assets Separately Reported, Securities Pledged as Collateral, at Fair Value	1,207		1,316
Available-for-sale Securities [Member]
Liabilities and Shareholders' Equity
Pledged Assets Separately Reported, Securities Pledged as Collateral, at Fair Value	$ 0		$ 369

[1] Includes trading securities pledged as collateral where counterparties have the right to sell or repledge the collateral of $1,207 million and $1,316 million at March 31, 2015 and December 31, 2014, respectively

[2] Includes securities AFS pledged as collateral where counterparties have the right to sell or repledge the collateral of $0 million and $369 million at March 31, 2015 and December 31, 2014, respectively.

[3] Includes $2.1 billion and $1.9 billion of LHFS carried at fair value at March 31, 2015 and December 31, 2014, respectively.

[4] Includes loans of consolidated VIEs of $277 million and $288 million at March 31, 2015 and December 31, 2014, respectively.

[5] None of the Company's repurchase or resell transactions met the right of setoff criteria for net balance sheet presentation at March 31, 2015 and December 31, 2014.

[6] Includes debt of consolidated VIEs of $292 million and $302 million at March 31, 2015 and December 31, 2014, respectively.

[7] Includes noncontrolling interest of $106 million and $108 million at March 31, 2015 and December 31, 2014, respectively.

[8] Includes restricted shares of 1,712 thousand and 2,930 thousand at March 31, 2015 and December 31, 2014, respectively.

[9] At March 31, 2015, includes ($1,215) million for treasury stock, ($15) million for compensation element of restricted stock, and $106 million for noncontrolling interest.At March 31, 2014, includes ($727) million for treasury stock, ($42) million for compensation element of restricted stock, and $126 million for noncontrolling interest.